Carbidopa recalls
The FDA has published 8 recalls involving Carbidopa since 2014. The latest was reported on 22 Oct 2025. Most were for potency & assay. Teva Pharmaceuticals USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls8since 2014
Last 12 months0reported
Class I00% of total
Ongoing1latest 22 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 8 100%Class III 0 0%
Why carbidopa is recalled
Companies
Brands
By year
Ongoing carbidopa recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg recalledCarbidopa, Levodopa And Entacapone | Rising Pharma Holding | Packaging Defects | Nationwide |
All carbidopa recalls, newest first
8 totalShould you stop taking Carbidopa?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.